Literature DB >> 11124829

Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes.

R Carini1, M G De Cesaris, R Splendore, D Vay, C Domenicotti, M P Nitti, D Paola, M A Pronzato, E Albano.   

Abstract

Ischemic preconditioning improves liver resistance to hypoxia and reduces reperfusion injury following transplantation. However, the intracellular signals that mediate the development of liver hypoxic preconditioning are largely unknown. We have investigated the signal pathway leading to preconditioning in freshly isolated rat hepatocytes. Hepatocytes were preconditioned by 10-minute incubation under hypoxic conditions followed by 10 minutes of reoxygenation and subsequently exposed to 90 minutes of hypoxia. Preconditioning reduced hepatocyte killing by hypoxia by about 35%. A similar protection was also obtained by preincubation with chloro-adenosine or with A(2A)-adenosine receptor agonist CGS21680, whereas A(1)-adenosine receptor agonist N-phenyl-isopropyladenosine (R-PIA) was inactive. Conversely, the development of preconditioning was blocked by A(2)-receptor antagonist 3,7-dimethyl-1-propargylxanthine (DMPX), but not by A(1)-receptor antagonist 8-cyclopenthyl-1, 3-dipropylxanthine (DPCPX). In either preconditioned or CGS21680-treated hepatocytes a selective activation of delta and epsilon protein kinase C (PKC) isoforms was also evident. Inhibition of heterotrimeric G(i) protein or of phospholypase C by, respectively, pertussis toxin or U73122, prevented PKC activation as well as the development of preconditioning. MEK inhibitor PD98509 did not interfere with preconditioning that was instead blocked by p38 MAP kinase inhibitor SB203580. The direct activation of p38 MAPK by anisomycin A mimicked the protection against hypoxic injury given by preconditioning. Consistently, an increased phosphorylation of p38 MAPK was observed in preconditioned or CGS21680-treated hepatocytes, and this effect was abolished by PKC-blocker, chelerythrine. We propose that a signal pathway involving A(2A)-adenosine receptors, G(i)-proteins, phospholypase C, delta- and epsilon-PKCs, and p38 MAPK, is responsible for the development of liver ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124829     DOI: 10.1053/jhep.2001.21050

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

Review 1.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  Redox therapeutics in hepatic ischemia reperfusion injury.

Authors:  Rakesh P Patel; John D Lang; Alvin B Smith; Jack H Crawford
Journal:  World J Hepatol       Date:  2014-01-27

4.  Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.

Authors:  Hao Wang; Yu Tina Zhao; Shouyan Zhang; Patrycja M Dubielecka; Jianfeng Du; Naohiro Yano; Y Eugene Chin; Shougang Zhuang; Gangjian Qin; Ting C Zhao
Journal:  J Cell Physiol       Date:  2017-05-03       Impact factor: 6.384

5.  How to protect liver graft with nitric oxide.

Authors:  Hassen Ben Abdennebi; Mohamed Amine Zaoualí; Izabel Alfany-Fernandez; Donia Tabka; Joan Roselló-Catafau
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

6.  Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers.

Authors:  Marta Massip-Salcedo; Araní Casillas-Ramirez; Rosah Franco-Gou; Ramón Bartrons; Ismail Ben Mosbah; Anna Serafin; Joan Roselló-Catafau; Carmen Peralta
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

7.  Induction of ischemic tolerance in rat liver via reduced nicotinamide adenine dinucleotide phosphate oxidase in Kupffer cells.

Authors:  Kazuaki Tejima; Masahiro Arai; Hitoshi Ikeda; Tomoaki Tomiya; Mikio Yanase; Yukiko Inoue; Takako Nishikawa; Naoko Watanabe; Natsuko Ohtomo; Masao Omata; Kenji Fujiwara
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Stimulation of p38 MAPK by hormonal preconditioning with atrial natriuretic peptide.

Authors:  Alexandra K Kiemer; Stefanie Kulhanek-Heinze; Tobias Gerwig; Alexander L Gerbes; Angelika M Vollmar
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.

Authors:  Alexander Choukèr; Akio Ohta; André Martignoni; Dmitriy Lukashev; Lefteris C Zacharia; Edwin K Jackson; Jürgen Schnermann; Jerrold M Ward; Ines Kaufmann; Brenda Klaunberg; Michail V Sitkovsky; Manfred Thiel
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

10.  [Ischemic preconditioning in a rat adipocutaneous flap model].

Authors:  A Dacho; S Lyutenski; G Aust; A Dietz
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.